• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Abbott Labs

edit

Abbott Molecular Inc., a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases. It currently markets seven U.S. Food and Drug Administration or foreign cleared or approved clinical products in addition to distributing over 300 Analyte Specific Reagent and research products through its direct sales operations in the United States and Europe and a worldwide distribution network covering 59 countries. The company was founded in 1991 and is based in Des Plaines, Illinois. As on 12/05/2001, Abbott Molecular Inc. operates as a subsidiary of Abbott Laboratories Inc.

Milestones

edit

• 
  Abbott Labs added John L. Bishop as CEO.
  Posted 9/4/09 at 6:01am
• 
  Abbott Labs added Jeffrey Boily as Division Director.
  Posted 9/3/08 at 1:51pm
• 
  Abbott Labs invested in Ovalis. (1/30/07)
  Posted 3/16/10 at 1:23am via onbiovc.com
• 
  Abbott Labs invested in Evalve. (11/27/07)
  Posted 9/17/09 at 6:59am via venturebeat.com
• 
  Went public with stock symbol NYSE:ABT.
  Posted 3/10/10 at 2:57am
• 
  Abbott Labs acquired Facet Biotech for $450M. (3/9/10)
  Posted 3/10/10 at 2:56am via fiercebiotech.com
• 
  Abbott Labs acquired Solvay Pharmaceuticals for $6.6B. (9/28/09)
  Posted 9/29/09 at 11:02am via fiercebiotech.com
• 
  Abbott Labs acquired Visiogen for $400M. (9/3/09)
  Posted 9/24/09 at 4:33pm via smartmoney.com
• 
  Abbott Labs acquired Evalve for $410M. (9/11/09)
  Posted 9/24/09 at 3:23pm via fiercepharma.com
• 
  Abbott Labs acquired Ibis Biosciences for $215M. (12/17/08)
  Posted 9/4/09 at 6:02am via reuters.com

Videos

Screenshots

edit

Stock Price

Traffic Analytics

Quantcast

Compete

Sources

1. Abbott buys Facet Biotech for $450M (fiercebiotech.com) [edit]
2. Abbott to buy Solvay pharma unit in $6.6B deal (fiercebiotech.com) [edit]
3. Studies find Botox cuts migraine days; Abbott to buy Evalve for up to $410M (fiercepharma.com) [edit]
4. Abbott To Pay $400 Million For Cataract-Treatment Firm Visiogen (smartmoney.com) [edit]
5. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis (reuters.com) [edit]
6. Evalve pulls in $60M, heating up heart-valve implant race (venturebeat.com) [edit]
7. Ovalis, Inc.: Series B $6.6M (onbiovc.com) [edit]

Share this page on Twitter or Facebook: Or copy this code to embed a widget: customize »